|
|
||||||||
European Journal of Cardio-Thoracic Surgery, Vol 6, 274-277, Copyright © 1992 by European Association for Cardio-thoracic Surgery
W Konertz, M Weyand, A Sidiropoulos, E Schwammenthal, G Breithardt and HH Scheld
Aortic valve replacement with a stentless device ought to result in
superior hemodynamic function, because obstructing stents and sewing rims
are eliminated. From 15 June 1991 to 15 October 1991, 15 patients underwent
aortic valve replacement with the newly designed Edwards stentless aortic
bioprosthesis 2500. Patients' ages ranged from 51 to 70 years (mean 61
years). Preoperatively 4 patients presented with aortic regurgitation, 7
with aortic stenosis and 4 with combined lesions; 7 patients were male and
8 female. No additional cardiac or noncardiac diseases were encountered.
The operations were performed under normothermic extracorporeal
cardiopulmonary bypass and cold cardioplegic cardiac arrest. The implanted
valves ranged from 21 mm to 27 mm in diameter. Ten patients received a
subcoronary implantation with the lower row of stitches made up of
interrupted sutures and the upper row of a continuous suture. In 5 patients
the so-called miniroot technique was used, also with lower interrupted
sutures and running upper sutures, after adaptation of coronary ostia to
the performed openings in the graft. Aortic cross-clamp time ranged between
73 min and 94 min (mean 82 min). There was no operative mortality or
morbidity. Postoperative echocardiography showed no signs of aortic valve
regurgation in any patient and continuous wave-Doppler measurements showed
that resting pressure gradients across the aortic valve were absent or low.
Our preliminary experiences with a stentless aortic xenograft valve show
that in presence of an increased cross- clamp time an improved hemodynamic
function will be obtained. Further studies will be needed, however, to
establish the long-term behavior of this device.
ARTICLES
Technique of aortic valve replacement with the Edwards stentless aortic bioprosthesis 2500
Department of Cardiothoracic Surgery, Westphalian Wilhelm's University Munster, FRG.
This article has been cited by other articles:
![]() |
J. Nowell, E. Wilton, H. Markus, and M. Jahangiri Antithrombotic therapy following bioprosthetic aortic valve replacement Eur. J. Cardiothorac. Surg., April 1, 2007; 31(4): 578 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Konertz Stentless Aortic Xenograft Heart Valves Asian Cardiovasc Thorac Ann, March 1, 2003; 11(1): 1 - 2. [Full Text] [PDF] |
||||
![]() |
A. R. Akar, A. Szafranek, C. Alexiou, R. Janas, M. J. Jasinski, J. Swanevelder, and A. W. Sosnowski Use of stentless xenografts in the aortic position: determinants of early and late outcome Ann. Thorac. Surg., November 1, 2002; 74(5): 1450 - 1457. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Milano, C. Blanzola, G. Mecozzi, A. D'Alfonso, M. De Carlo, C. Nardi, and U. Bortolotti Hemodynamic performance of stented and stentless aortic bioprostheses Ann. Thorac. Surg., July 1, 2001; 72(1): 33 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Bortolotti, G. Scioti, A. Milano, G. Borzoni, C. Nardi, and G. Tartarini The Edwards Prima stentless valve: hemodynamic performance at one year Ann. Thorac. Surg., December 1, 1999; 68(6): 2147 - 2151. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Del Rizzo, B. S. Goldman, G. T. Christakis, and T. E. David HEMODYNAMIC BENEFITS OF THE TORONTO STENTLESS VALVE J. Thorac. Cardiovasc. Surg., December 1, 1996; 112(6): 1431 - 1446. [Abstract] [Full Text] |
||||
![]() |
N. D. Kon, S. Westaby, N. Amarasena, R. Pillai, and A. R. Cordell Comparison of Implantation Techniques Using Freestyle Stentless Porcine Aortic Valve Ann. Thorac. Surg., April 1, 1995; 59(4): 857 - 862. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |